Percheron Therapeutics Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.716x

Percheron Therapeutics Ltd cash flow conversion efficiency. Based on the latest financial reports, Percheron Therapeutics Ltd (PER) has a cash flow conversion efficiency ratio of -0.716x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.16 Million ≈ $-5.07 Million USD) by net assets (AU$10.00 Million ≈ $7.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Percheron Therapeutics Ltd (2002–2025)

Cash flow conversion efficiency of Percheron Therapeutics Ltd from 2002 to 2025. This chart illustrates how Percheron Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PER live share price for real-time trading data and today's change.

Percheron Therapeutics Ltd Cash Flow Conversion Ratio Explained

Percheron Therapeutics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Percheron Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Percheron Therapeutics Ltd ranked by their cash flow conversion efficiency. Also see market cap of Percheron Therapeutics Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Jeffs' Brands Ltd NASDAQ:JFBR	-0.295x
Tri Banyan Tirta Tbk JK:ALTO	0.004x
Nrgene Technologies Ltd TA:NRGN	0.392x
N. Leventeris S.A. AT:LEBEK	-0.132x
Limas Indonesia Makmur Tbk JK:LMAS	0.000x
Socket Mobile Inc NASDAQ:SCKT	0.057x
Baronsmead Venture Trust Plc LSE:BVT	-0.005x
Site Group International Ltd AU:SIT	0.088x

Annual Cash Flow Conversion Efficiency for Percheron Therapeutics Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Percheron Therapeutics Ltd from 2002 to 2025. Review PER FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$10.00 Million ≈ $7.08 Million	AU$-15.64 Million ≈ $-11.07 Million	-1.564x	-44.74%
2024-06-30	AU$9.36 Million ≈ $6.62 Million	AU$-10.12 Million ≈ $-7.16 Million	-1.080x	-32.22%
2023-06-30	AU$9.98 Million ≈ $7.06 Million	AU$-8.15 Million ≈ $-5.77 Million	-0.817x	-121.33%
2022-06-30	AU$21.14 Million ≈ $14.96 Million	AU$-7.81 Million ≈ $-5.52 Million	-0.369x	+63.76%
2021-06-30	AU$5.73 Million ≈ $4.05 Million	AU$-5.83 Million ≈ $-4.13 Million	-1.019x	-16.98%
2020-06-30	AU$4.53 Million ≈ $3.21 Million	AU$-3.95 Million ≈ $-2.79 Million	-0.871x	+16.46%
2019-06-30	AU$2.81 Million ≈ $1.99 Million	AU$-2.93 Million ≈ $-2.07 Million	-1.042x	-91.14%
2018-06-30	AU$4.22 Million ≈ $2.99 Million	AU$-2.30 Million ≈ $-1.63 Million	-0.545x	+65.32%
2017-06-30	AU$1.85 Million ≈ $1.31 Million	AU$-2.91 Million ≈ $-2.06 Million	-1.572x	-255.40%
2016-06-30	AU$4.58 Million ≈ $3.24 Million	AU$-2.03 Million ≈ $-1.43 Million	-0.442x	-347.26%
2015-06-30	AU$7.09 Million ≈ $5.02 Million	AU$1.27 Million ≈ $897.81K	0.179x	+112.01%
2014-06-30	AU$2.09 Million ≈ $1.48 Million	AU$-3.11 Million ≈ $-2.20 Million	-1.489x	-144.27%
2013-06-30	AU$4.65 Million ≈ $3.29 Million	AU$-2.83 Million ≈ $-2.00 Million	-0.610x	-33.48%
2012-06-30	AU$5.27 Million ≈ $3.73 Million	AU$-2.41 Million ≈ $-1.70 Million	-0.457x	+50.63%
2011-06-30	AU$2.02 Million ≈ $1.43 Million	AU$-1.87 Million ≈ $-1.32 Million	-0.925x	+6.96%
2010-06-30	AU$1.34 Million ≈ $951.04K	AU$-1.34 Million ≈ $-945.75K	-0.994x	-18.94%
2009-06-30	AU$3.93 Million ≈ $2.78 Million	AU$-3.28 Million ≈ $-2.32 Million	-0.836x	-55.71%
2008-06-30	AU$6.33 Million ≈ $4.48 Million	AU$-3.40 Million ≈ $-2.41 Million	-0.537x	-20.59%
2007-06-30	AU$6.02 Million ≈ $4.26 Million	AU$-2.68 Million ≈ $-1.90 Million	-0.445x	+1.08%
2006-06-30	AU$8.79 Million ≈ $6.22 Million	AU$-3.96 Million ≈ $-2.80 Million	-0.450x	+12.43%
2005-06-30	AU$10.86 Million ≈ $7.69 Million	AU$-5.59 Million ≈ $-3.95 Million	-0.514x	-298.62%
2004-06-30	AU$17.13 Million ≈ $12.12 Million	AU$-2.21 Million ≈ $-1.56 Million	-0.129x	+57.16%
2002-06-30	AU$13.48 Million ≈ $9.54 Million	AU$-4.06 Million ≈ $-2.87 Million	-0.301x	--

About Percheron Therapeutics Ltd

AU:PER Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.31 Million

AU$3.26 Million AUD

Market Cap Rank

#29844 Global

#1707 in Australia

Share Price

AU$0.00

Change (1 day)

+0.00%

52-Week Range

AU$0.00 - AU$0.01

All Time High

AU$0.34